Account
Vizeum bags media duties of JetPrivilege
MUMBAI: Year 2015 seems to have started on a good note for Vizeum India, the media communication specialist from the Dentsu Aegis Network. The agency has been appointed as the media AoR for Jet Privilege (JPPL), a specialised loyalty and rewards management company.
This comes close on the heels of the agency winning the media mandate for Hindware last week.
As JPPL is looking at growing its business innovatively, Vizeum has been brought on board as strategic consultants in the area of tangible consumer connections.
JPPL managing director Manish Dureja said, “JetPrivilege is pleased to be associated with Vizeum, a leading global media agency and we are confident that they will add value to our business.”
Vizeum Indian subcontinent managing director S Yesudas added, “It is an absolute honor for us to be working with a fast growing company like JetPrivilege. Vizeum is an experience-to-believe-it agency. Our DNA is to delight our clients. JPPL-Vizeum relationship is not limited to the core deliverables of a media agency. We are eager to add a lot more value to the overall business of the client. This business will be handled out of our Mumbai office under the leadership of Vizeum EVP Samarjit Rajkumar.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
